SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco is currently trending as investors monitor its resilience amid macroeconomic volatility and ongoing debates surrounding the impact of potential tariff refunds on retail pricing. The community remains focused on Costco's defensive strengths, with frequent discussions centered on its robust membership renewal rates, traffic growth, and valuation relative to the broader consumer staples sector.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics is generating significant investor interest driven by high trading volumes, active momentum in its clinical-stage pipeline, and multiple analyst endorsements from firms like Guggenheim and HC Wainwright. Community discussion is focused on the high-stakes Phase 2 LOTUS trial readout expected in 2026 and ongoing debates regarding the company's financial risk profile versus the potential upside of its immunology platform.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a focal point for the community due to renewed institutional interest, shifting ecosystem management, and ongoing discussions regarding its quantum-resistant technology. While some traders debate the asset's long-term viability following historic price volatility, active participants are heavily focused on potential regulatory catalysts and the ongoing expansion of its real-world asset (RWA) utility.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF is capturing investor attention as they rotate toward defensive, value-oriented positions amidst broader market volatility. The community is actively debating the fund's resilience, with many investors maintaining a long-term 'buy and hold' strategy despite recent stagnant performance, while others monitor the ETF's sector diversification and dividend growth potential as a reliable hedge.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community speculates on a major upcoming partnership announcement, with many pointing to a connection with Stellar or a potential collaboration with Ripple/XRP at an upcoming industry event. Investors are actively debating the project's long-term utility in global payroll and real-world adoption, balancing high-conviction sentiment against skepticism regarding its price performance and market volatility.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is currently trending due to intense volatility following a quarterly earnings report that featured a strong double beat on top and bottom lines but provided cautious forward revenue guidance. The community is actively debating whether the double-digit price decline is a baseless overreaction caused by market makers or a justified correction given the stock's high valuation and competitive concerns within the AI infrastructure sector.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors weigh the potential impact of looming pharmaceutical tariffs, which are pushing the company to increase its U.S. manufacturing footprint. Simultaneously, the community is actively debating the company's aggressive M&A strategy, particularly its focus on expanding oncology and T-cell engager therapy pipelines, while keeping a watchful eye on patent litigation risks.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as the community debates its long-term viability, with supporters pointing to upcoming regulatory clarity like the Clarity Act and existing infrastructure partnerships, while skeptics emphasize a prolonged downward price trend and lack of active communication from project leadership.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is a primary focal point of market discourse following the FDA approval of Foundayo, its once-daily oral GLP-1 weight-loss pill, which analysts view as a major step toward expanding the obesity treatment market through improved convenience and scalability. While community discussion remains intense regarding its competitive positioning against Novo Nordisks oral offerings, the broader pharma sector is also digesting the implications of potential new pharmaceutical tariff policies and ongoing M&A activity, keeping Eli Lillys valuation and long-term growth trajectory at the center of investor focus.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is seeing significant market activity and heightened community discourse driven by persistent acquisition rumors and notable institutional volume in after-hours trading. Traders are actively debating the stock's valuation relative to its rare disease pipeline, while observing unconventional trading patterns that have fueled speculation of a potential buyout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is First Trust Rising Dividend Achievers ETF (RDVY) a Strong ETF Right Now?

<ul class="summary-bullets"><li>State Street during the conference said that it expects its current quarter revenue to grow in ‘low teens’ compared to the year-ago quarter.&nbsp;</li><li>STT executive said the bank&nbsp;expects similar growth like revenue in its fees and NII in Q1 2026.</li></ul>A State Street executive on Monday while presenting at the RBC Capital Markets Global Financial Institutions Conference said that its first-quarter results are ‘expected to be better than what we envisioned'. Shares closed nearly 3% higher on Wednesday.&nbsp;"So while weakened dollar is relatively neutral to our overall operating leverage, we do expect a couple of percentage points of impact on both revenue and expense on a year over year basis. So you want to take that into consideration in a little extra color there. So overall, to wrap up, you know, results are expected to be better than what we envisioned for the first quarter back in January,” the executive said.&nbsp;“We remain confident in our ability to deliver another year of positive total operating leverage and pre-tax margin expansion across a range of scenarios, and we'll have a lot more to say and share on our full year expectations when we get back together again in about a month in mid-April to talk about the Q1 results,” executive added.&nbsp;<h2 class="st-heading-2">Q1 2026 Revenue</h2>State Street during the conference said that it expects its current quarter revenue to grow in ‘low teens’ compared to the year-ago quarter.&nbsp;"Right now, we're currently expecting the first quarter total revenue to increase in the low teens on a year over year basis, supported by similar growth in both fees and NII. And for the quarter, importantly, we expect to generate roughly 400 basis points of total operating leverage," he added.&nbsp;<h2 class="st-heading-2">STT Q4 Earnings</h2>State Street reported adjusted earnings per share of $2.97 for the&nbsp;fourth quarter, surpassing analyst estimates of $2.78 per share. Its revenue totaled $3.67 billion, beating consensus estimates of $3.57 billion and representing a 7% increase year-over-year, as per data from fiscal.ai.The company also saw its total expenses in the quarter increase by 12%, primarily driven by investments in its business and technology capabilities and revenue-related costs.Retail sentiment around STT trended in ‘neutral’ territory amid ‘normal’ message volume.Shares of State Street have fallen 2% year-to-date.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, State Street Corporation logo is seen on a smartphone screen. 

State Street Shares Rise As Exec Expects Q1 2026 Revenue To Exceed Former Expectations

“We'll have a lot more to say and share on our full year expectations when we get back together again in about a month in mid-April to talk about the Q1 results,” the bank's executive said in a conference.

Equity

“We'll have a lot more to say and share on our full year expectations when we get back together again in about a month in mid-April to talk about the Q1 results,” the bank's executive said in a conference.


<ul class="summary-bullets"><li>A sale process could kick off in the next few months and attract interest from private equity firms.</li><li>Baker Hughes is selling the non-core asset after agreeing last year to buy industrial equipment maker Chart Industries Inc. for about $9.6 billion in one of its biggest-ever acquisitions.&nbsp;</li><li>Baker Hughes on Wednesday said it has received a gas turbine order from Twenty20 Energy to power its U.S. data center infrastructure.&nbsp;</li></ul>Baker Hughes shares popped 4% on Wednesday as it reportedly explores a potential sale of its Waygate Technologies unit.&nbsp;Baker Hughes is selling the non-core asset after agreeing last year to buy industrial equipment maker Chart Industries Inc. for about $9.6 billion in one of its biggest-ever acquisitions.&nbsp;<h2 class="st-heading-2">Details</h2>The oilfield contractor is working with advisers to study a possible divestment of the Waygate business, which could fetch around $1.5 billion, a report from Bloomberg News said, citing people familiar with the matter.&nbsp;A sale process could kick off in the next few months and attract interest from private equity firms. Deliberations are ongoing and there’s no certainty they will lead to a transaction.&nbsp;Baker Hughes’ Chief Executive Officer Lorenzo Simonelli said in October that the company is undertaking a “comprehensive evaluation” of its capital allocation focus following the Chart deal in order to boost shareholder value, the report added.&nbsp;<h2 class="st-heading-2">Other News</h2>Baker Hughes on Wednesday said it has received a gas turbine order from Twenty20 Energy to power its U.S. data center infrastructure.&nbsp;Baker Hughes will supply 10 Frame 5 gas turbines and associated equipment for data center projects in the U.S.This order comes as Baker Hughes and Twenty20 Energy move toward a strategic agreement under which Baker Hughes will supply multi-gigawatt power generation equipment.“We are pleased to announce this initial order from Twenty20 Energy that reflects our shared commitment to providing reliable and secure power to support growth in critical data center infrastructure,” said Baker Hughes Chairman and CEO Lorenzo Simonelli.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around BKR trended in ‘bearish’ territory amid ‘high’ message volume.&nbsp;Shares in the company have risen nearly 30% over the past year.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/crypto-token-uni-rises-how-did-blackrock-drive-the-rally/cZb6jCHR4Ad">Crypto Token UNI Jumps 14% - How Did BlackRock Drive The Rally?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Baker Hughes facility is seen in Abu Dhabi, United Arab Emirates, on November 17, 2022. 

Why Is Baker Hughes Stock Rising Today?

The oilfield contractor is working with advisers to study a possible divestment of the Waygate business, which could fetch around $1.5 billion, as per Bloomberg report. 

Should First Trust Rising Dividend Achievers ETF (RDVY) Be on Your Investing Radar?

The Zacks Analyst Blog Highlights VIG, SDY, VYM and RDVY

VIG and other dividend ETFs gain attention as investors seek steady income amid economic slowdown and possible Fed rate cuts.

4 Dividend ETFs to Play for Steady Income

Fed rate-cut signals and economic uncertainty boost investor interest in dividend-focused ETFs like VIG and VYM for steady income.

Lennar (LEN) stock slipped 3% in after-hours trading on Thursday after the U.S. homebuilder posted a fall in first-quarter profit.The company reported a net income of $520 million, or $1.96 per share, for the three months ended Feb. 28, compared with $719 million, or $2.57 per share, in the year-ago quarter.Its quarterly revenue of $7.63 billion topped expectations of $7.43 billion, according to FinChat data.Lennar’s average home sales price, net of incentives, declined by 1% to $408,000.The company said new home deliveries rose to 17,834 homes in the first quarter from 16,798 homes a year earlier.“While demand remains strong, persistently higher interest rates and inflation, combined with a downturn in consumer confidence and a limited supply of affordable homes, made it increasingly difficult for consumers to access homeownership,” CEO Stuart Miller said.Its gross margins on home sales fell to $1.4 billion, or 18.7%, from $1.5 billion, or 21.8%, due to an increase in land costs year over year and a decrease in revenue per square foot.The company forecasted second–quarter new orders between 22,500 and 23,500 and deliveries between 19,500 and 20,500.Lennar expects the average sales price to fall into the range of $390,000 to $400,000.“Net prices for homes, together with rents in overbuilt apartment markets, have started to decline, as demand remains constrained by affordability," Miller added.Retail sentiment on Stocktwits moved to the ‘bullish’ (59/100) territory from ‘neutral’(47/100) a day ago, while retail chatter rose to ‘extremely high.’<figure class="image"><img src="https://news.stocktwits-cdn.com/LEN_March_21_JPG_a03bb45671.webp" alt="LEN’s Sentiment Meter and Message Volume as of 01:06 a.m. ET on March 21, 2025 | Source: Stocktwits"><figcaption>LEN’s Sentiment Meter and Message Volume as of 01:06 a.m. ET on March 21, 2025 | Source: Stocktwits</figcaption></figure>One bullish trader wondered if the stock would move higher in premarket trade.<stembedurl>https://stocktwits.com/Iluvoptions85/message/608778346</stembedurl>One retail trader said earnings were good but not “spectacular” and implied the stock would fall.<stembedurl>https://stocktwits.com/solosequenosenada/message/608753928</stembedurl><a href="https://stocktwits.com/symbol/LEN">Lennar shares</a> have fallen about 9% year-to-date (YTD).Also See: <a href="https://stocktwits.com/news-articles/markets/equity/fed-ex-slips-after-2025-forecast-cut-mixed-q3-earnings/ch78k78RbPV">FedEx Stock Slips After 2025 Forecast Cut, Mixed Q3 Earnings: Retail Sees Recession Warnings</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Close-up of a row of single family homes in Alexandria, Virginia. (Image courtesy: Grace Cary/Getty Images)

Lennar Stock Falls After Homebuilder’s Q1 Profit Takes A Hit, Retail’s Still Bullish

Its quarterly revenue of $7.63 billion topped expectations of $7.43 billion, according to FinChat data.

Lennar Stock Falls After Q1 Profit Falls

First Trust Exchange-Traded Fund VI - First Trust Rising Dividend Achievers ETF

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

RDVY
First Trust Exchange-Traded Fund III - First Trust Rising Dividend Achievers ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest RDVY News

RDVYFirst Trust Exchange-Traded Fund III - First Trust Rising Dividend Achievers ETF